Cognitive function, dementia and type 2 diabetes mellitus in the elderly
- PMID: 21263438
- DOI: 10.1038/nrendo.2010.228
Cognitive function, dementia and type 2 diabetes mellitus in the elderly
Abstract
Increasing numbers of people are developing type 2 diabetes mellitus, but interventions to prevent and treat the classic microvascular and macrovascular complications have improved, so that people are living longer with the condition. This trend means that novel complications of type 2 diabetes mellitus, which are not targeted by current management strategies, could start to emerge. Cognitive impairment and dementia could come into this category. Type 2 diabetes mellitus is associated with a 1.5-2.5-fold increased risk of dementia. The etiology of dementia and cognitive impairment in people with type 2 diabetes mellitus is probably multifactorial. Chronic hyperglycemia is implicated, perhaps by promoting the development of cerebral microvascular disease. Data suggest that the brains of older people with type 2 diabetes mellitus might be vulnerable to the effects of recurrent, severe hypoglycemia. Other possible moderators of cognitive function include inflammatory mediators, rheological factors and dysregulation of the hypothalamic-pituitary-adrenal axis. Cognitive function should now be included as a standard end point in randomized trials of therapeutic interventions in patients with type 2 diabetes mellitus.
Similar articles
-
R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia.Diabet Med. 2011 Feb;28(2):141-7. doi: 10.1111/j.1464-5491.2010.03199.x. Diabet Med. 2011. PMID: 21219420
-
Type 2 diabetes and risk of cognitive impairment and dementia.Curr Neurol Neurosci Rep. 2007 Sep;7(5):373-80. doi: 10.1007/s11910-007-0058-7. Curr Neurol Neurosci Rep. 2007. PMID: 17764626 Review.
-
[The effect of hyper- and hypoglycaemia on cognition and development of dementia for patients with diabetes mellitus Type 2].Ugeskr Laeger. 2018 Dec 17;180(51):V08180566. Ugeskr Laeger. 2018. PMID: 30618361 Danish.
-
The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies.Diabetes Obes Metab. 2009 May;11(5):407-14. doi: 10.1111/j.1463-1326.2008.00963.x. Diabetes Obes Metab. 2009. PMID: 19422401 Review.
-
Cognitive dysfunction in patients with type 2 diabetes.Diabetes Metab Res Rev. 2010 Oct;26(7):507-19. doi: 10.1002/dmrr.1112. Diabetes Metab Res Rev. 2010. PMID: 20799243 Review.
Cited by
-
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1037-1045. doi: 10.1016/j.bbadis.2016.04.017. Epub 2016 May 6. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 27156888 Free PMC article. Review.
-
Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus.Diabetes Metab J. 2016 Dec;40(6):423-432. doi: 10.4093/dmj.2016.40.6.423. Epub 2016 Oct 5. Diabetes Metab J. 2016. PMID: 27766794 Free PMC article. Review.
-
Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine.Int J Endocrinol. 2015;2015:810439. doi: 10.1155/2015/810439. Epub 2015 Apr 28. Int J Endocrinol. 2015. PMID: 26060494 Free PMC article. Review.
-
Cognitive functions in middle aged individuals are related to metabolic disturbances and aerobic capacity: a cross-sectional study.PLoS One. 2012;7(12):e51132. doi: 10.1371/journal.pone.0051132. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251434 Free PMC article.
-
Interleukin-5: an indicator of mild cognitive impairment in patients with type 2 diabetes mellitus - a comprehensive investigation ranging from bioinformatics analysis to clinical research.J Endocrinol Invest. 2024 Sep 30. doi: 10.1007/s40618-024-02430-2. Online ahead of print. J Endocrinol Invest. 2024. PMID: 39347908
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical